BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,988,000 | +53.6% | 26,380 | +48.0% | 0.01% | +57.1% |
| Q2 2022 | $2,597,000 | +164.5% | 17,820 | +24.1% | 0.01% | +133.3% |
| Q1 2021 | $982,000 | -24.5% | 14,364 | -5.3% | 0.00% | -40.0% |
| Q4 2020 | $1,300,000 | -21.0% | 15,167 | -41.8% | 0.01% | -37.5% |
| Q3 2020 | $1,645,000 | +29.5% | 26,040 | +50.0% | 0.01% | 0.0% |
| Q2 2020 | $1,270,000 | +12.7% | 17,360 | -42.1% | 0.01% | 0.0% |
| Q3 2018 | $1,127,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |